Alicia Secor

CIK 1584516 · President and CEO · last filed 2025-12-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

31

Lifetime Open-Market Net

-$1.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZVRA Director $12.65 $0 1 2025-12-09
G1 Therapeutics, Inc. (GTHX) Delisted Director 0 $7.15 $0 $0 5 2024-09-18
Orchard Therapeutics plc (ORTX) Delisted Director $16.70 $0 5 2024-01-24
GW PHARMACEUTICALS PLC (GWPH) Delisted Director 11,844 $218.96 $2.59M -$36.7K 9 2021-03-02
JUNIPER PHARMACEUTICALS INC (JNP) Delisted President and CEO 0 $28.8K 6 2018-08-15
Larimar Therapeutics, Inc. (ZFGN) Delisted Chief Commercial Officer 5,256 -$1.08M 3 2016-04-04
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted SVP, Chief Operating Officer $0 1 2013-09-23

Recent Filings · Page 4 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-09-23 SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Grant (A) $0 EDGAR
Showing 3131 of 31
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.